-   Training & Support

[Expand/Collapse all sections]Expand all

This document outlines details of PBS-subsidised tocilizumab for
patients with active Giant cell arteritis (GCA).

GCA and listing dates

GCA is an inflammation of blood vessels in and around the scalp.

Listing date:

-   tocilizumab – 1 August 2019

Note: patients must be aged 50 years or older.

Enquiries

Transfer enquiries about prescription arrangements to the PBS Complex
Drugs Program team and choose the option relevant to the condition
treated.

The Resources page contains links to application forms, contact details,
item and restriction codes, the PBS schedule and the Services Australia
website.

Related links

Online Pharmaceutical Benefits Scheme (PBS) Authorities System (OPA
System)

Processing and National Demand Allocation (PaNDA)

Processing Complex Authority Required Listings

Written Authority Required Drugs

                                   

-   Services Australia ABN 90 794 605 008 
